Total Number of Communication Reports: 55
Monthly communication reports in the last 6 months: 0
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide.
Michael Berendt, CEO
End date of the last completed financial year: 2013-06-30
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
National Research Council (NRC) | $118,901.00 | Yes |
Address:
231 Dundas Street East
P.O. Box 1570
Belleville, ON K8N 5J2
Canada
Telephone number:
613-966-8058
Fax number:
613-966-4049
Bioniche Life Sciences Inc. is not a subsidiary of any other parent companies.
Bioniche Life Sciences Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
Bioniche Life Sciences Inc. | 2008-08-07 | 2015-04-02 |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|---|---|
Michael Berendt | 2013-11-04 | 2015-04-02 |
Graeme McRae | 2005-08-19 | 2013-11-04 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.